fingolimod hydrochloride has been researched along with Respiratory Syncytial Virus Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hartwig, SM; Luangrath, MA; Schmidt, ME; Varga, SM | 1 |
1 other study(ies) available for fingolimod hydrochloride and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Tissue-Resident Memory T Cells in the Lungs Protect against Acute Respiratory Syncytial Virus Infection.
Topics: Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Epitopes, T-Lymphocyte; Female; Fingolimod Hydrochloride; Immunologic Memory; Influenza Vaccines; Lung; Memory T Cells; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Vaccines, Synthetic | 2021 |